1345866-66-1
Chemical Structure
4-(6-Methyl-1,2,4,5-tetrazin-3-yl)benzoic acid
- CAS No.: 1345866-66-1
- Formula:C10H8N4O2
- Molecular Weight:216.20
IUPAC Name: 4-(6-methyl-1,2,4,5-tetrazin-3-yl)benzoic acid
InChIKey: VIRCHPVFFZGAJH-UHFFFAOYSA-N
SMILES: O=C(O)C=1C=CC(=CC1)C2=NN=C(N=N2)C
Biological Activity: 4-(6-Methyl-1,2,4,5-tetrazin-3-yl) benzoic acid is an asymmetric tetrazine derivative and a bioorthogonal reaction partner. 4-(6-Methyl-1,2,4,5-tetrazin-3-yl) benzoic acid can be conjugated with Bevacizumab (HY-P9906) via EDC/NHS activation while retaining the VEGF-binding affinity of the antibody, thus constructing a targeting agent for pretargeted immuno-PET/NIRF imaging[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
4-(6-Methyl-1,2,4,5-tetrazin-3-yl)benzoic acid | 4-(6-Methyl-1,2,4,5-tetrazin-3-yl) benzoic acid is an asymmetric tetrazine derivative and a bioorthogonal reaction partner. 4-(6-Methyl-1,2,4,5-tetrazin-3-yl) benzoic acid can be conjugated with Bevacizumab (HY-P9906) via EDC/NHS activation while retaining the VEGF-binding affinity of the antibody, thus constructing a targeting agent for pretargeted immuno-PET/NIRF imaging. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
[1]. Xudong Shi, et al. 64Cu-Based Pretargeted Immuno-Positron Emission Tomography
and Near-Infrared Fluorescence Imaging of the Vascular Endothelial
Growth Factor. ACS Omega 2019, 4, 5310-5316. -
[2]. Steffen A. Busche, et al. Tetrazine-norbornene versus azide-norbornene ligation: evaluating the toolbox for polymer-polymer coupling. Polym. Chem., 2023, 14,
2888.